Celastrol attenuates the invasion and migration and augments the anticancer effects of olaparib in prostate cancer
Abstract Background Prostate cancer (PCa) is a leading malignancy among men globally, with rising incidence rates emphasizing the critical need for better detection and therapeutic approaches. The roles of HSP90AB1 and PARP1 in prostate cancer cells suggest potential targets for enhancing treatment...
Saved in:
| Main Authors: | Mengqiu Huang, Lin Chen, Xiaoyan Ma, Houqiang Xu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2024-10-01
|
| Series: | Cancer Cell International |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12935-024-03542-8 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The poly (ADP-ribose) polymerase inhibitor olaparib attenuates established pulmonary fibrosis in a large animal model
by: Habtamu B. Derseh, et al.
Published: (2025-08-01) -
Thioparib inhibits homologous recombination repair, activates the type I IFN response, and overcomes olaparib resistance
by: Li‐Min Wang, et al.
Published: (2023-01-01) -
Dose-dependent immunotoxic mechanisms of celastrol via modulation of the PI3K-Akt signaling pathway
by: Shaohui Geng, et al.
Published: (2025-05-01) -
Development and evaluation of a 99mTc-labeled olaparib analog for PARP imaging
by: Wei Xu, et al.
Published: (2025-07-01) -
Olaparib induced aplastic anemia in a patient with castrate resistant prostate cancer: A case report
by: Elrazi A Ali, et al.
Published: (2024-01-01)